This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Agouron Pharmaceuticals, Inc.. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: Inventor Nebojsa Slobodan Stankovic: Pioneering Protein Kinase Modulation
Introduction
Nebojsa Slobodan Stankovic is an innovative inventor based in San Diego, California, renowned for his contributions in the field of medicinal chemistry. With a focus on advancing the development of therapeutic compounds, he has made significant strides through his research and expertise.
Latest Patents
Stankovic holds a patent titled "Methods of Preparing Indazole Compounds," which pertains to novel methods for synthesizing indazole compounds. These compounds exhibit potential as modulators and/or inhibitors of protein kinases, which are essential in various biological pathways. The invention also details intermediate compounds that facilitate the preparation of these therapeutic agents.
Career Highlights
Currently, Stankovic is associated with Agouron Pharmaceuticals, Inc., where he applies his expertise in pharmaceutical research and development. His work contributes to the company's aim of developing innovative therapies that target critical health issues.
Collaborations
Throughout his career, Stankovic has collaborated with talented colleagues, including Brigitte Leigh Ewanicki and Erik Jon Flahive. These collaborations highlight the importance of teamwork in driving forward cutting-edge research and the successful development of new pharmaceutical compounds.
Conclusion
Nebojsa Slobodan Stankovic's contributions to the field of medicinal chemistry underscore his role as an influential inventor. Through his patent on indazole compounds and his work at Agouron Pharmaceuticals, he continues to be a vital asset in the pursuit of innovative therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile